A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.

Jean-Paul Sculier,Marianne Paesmans,Jean-Paul Lecomte,O Van Cutsem,Jean-Jacques Lafitte,Thierry Berghmans,George Koumakis,M.C. Florin,Jacques Thiriaux,J. Michel,Vicente Giner,M.C. Berchier,Paul Mommen,Vincent Ninane,Jean Klastersky

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.

2001

Jean-Paul Sculier
Marianne Paesmans
Jean-Paul Lecomte
O Van Cutsem
Jean-Jacques Lafitte
Thierry Berghmans
George Koumakis
M.C. Florin
Jacques Thiriaux
J. Michel
Vicente Giner
M.C. Berchier
Paul Mommen
Vincent Ninane
Jean Klastersky

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

Keywords:

Small-cell carcinoma
Ifosfamide
Vindesine
Pathology
Cancer
Immunology
Medicine
Epirubicin
Lung cancer
Chemotherapy
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations